We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 03, 2020

Outcomes Similar Following Total Body Irradiation–Based and Chemotherapy-Based Myeloablative Conditioning of Haploidentical HCT for AML

American Journal of Hematology


Additional Info

American Journal of Hematology
Impact of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning on Outcomes of Haploidentical Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia
Am. J. Hematol 2020 Jul 13;[EPub Ahead of Print], B Dholaria, M Labopin, E Angelucci, F Ciceri, JL Diez-Martin, B Bruno, S Sica, Y Koc, Z Gülbas, C Schmid, D Blaise, AM Carella, G Visani, BN Savani, A Nagler, M Mohty

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading